List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 138 studies with search of:   Serbia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
2 Active, not recruiting Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Condition: Asthma
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Fluticasone propionate and salmeterol (F/SC) DPI
3 Recruiting A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)
Condition: Ulcerative Colitis
Interventions: Biological: Placebo;   Biological: Golimumab, placebo;   Biological: golimumab, placebo
4 Completed Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Condition: Atrial Fibrillation
Interventions: Drug: Placebo;   Drug: Vernakalant (oral)
5 Active, not recruiting A Study of Eszopiclone Co-Administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia
Conditions: Major Depressive Disorder;   Insomnia
Interventions: Drug: Eszopiclone;   Drug: Placebo;   Drug: Venlafaxine
6 Completed Clinical Trial in Patients With Metastatic Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Interventions: Drug: CoFactor;   Drug: 5-FU;   Drug: Leucovorin
7 Active, not recruiting Randomized, Double-Blind Active Comparator-Controlled Study of Rivoglitazone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: placebo;   Drug: rivoglitazone HCl;   Drug: rivoglitazone HCl
8 Recruiting A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Conditions: Tumor;   Pain
Interventions: Drug: CG5503 ER;   Drug: Placebo to match CG5503;   Drug: Morphine Sulphate CR;   Drug: Placebo to match Morphine Sulphate CR
9 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
10 Completed Study of the Effect on Non-Small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)
Condition: Lung Cancer
Intervention: Drug: Motexafin Gadolinium
11 Completed Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).
Condition: Generalized Anxiety Disorder
Interventions: Drug: pregabalin;   Other: placebo
12 Recruiting Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: NOV-002 Injection, Oxidized Glutathione
13 Recruiting Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
14 Active, not recruiting Efficacy and Safety Study of TAK-491 Compared to Ramipril for Treating Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: TAK-491;   Drug: TAK-491;   Drug: Ramipril
15 Completed SLV308 for Treatment of Patients With Early Parkinson's Disease
Condition: Early Stage Parkinson's Disease
Interventions: Drug: pardoprunox;   Drug: Pardoprunox;   Drug: Pardoprunox;   Drug: Placebo
16 Recruiting Zalutumumab in Patients With Non-Curable Head and Neck Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Interventions: Drug: Zalutumumab;   Other: Best Supportive Care
17 Terminated Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: DOV 21, 947;   Drug: Placebo
18 Recruiting Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
19 Recruiting Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
20 Completed Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: etanercept

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services